⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7057565 | 0.64 | — | — | |
| SCHEMBL131923 | 0.64 | — | — | |
| SCHEMBL14477548 | 0.61 | — | — | |
| SCHEMBL4507474 | 0.58 | — | — | |
| SCHEMBL5968783 | 0.58 | — | — | |
| SCHEMBL4507479 | 0.58 | — | — | |
| SCHEMBL69353 | 0.58 | — | — | |
| SCHEMBL3267509 | 0.58 | — | — | |
| SCHEMBL9721257 | 0.56 | — | — | |
| Hydrochloric Acid SCHEMBL20996517 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510562-B | Synthesis method of medical intermediate 2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117551155-B | Synthesis method of 5'-O-DMT-2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117551155-A | Synthesis method of 5'-O-DMT-2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-117510562-A | Synthesis method of medical intermediate 2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-12637568-B2 | Curable hot-melt silicone composition, cured product thereof, and laminate including curable hot-melt silicone composition or cured product thereof | DOW TORAY CO., LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| CN-117510562-B | Synthesis method of medical intermediate 2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117510562-B | Synthesis method of medical intermediate 2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117551155-B | Synthesis method of 5'-O-DMT-2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117551155-A | Synthesis method of 5'-O-DMT-2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117510562-A | Synthesis method of medical intermediate 2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117510562-A | Synthesis method of medical intermediate 2' -O-propynyl-uridine | 苏州诺维康生物科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| US-20230151215-A1 | CURABLE HOT-MELT SILICONE COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE INCLUDING CURABLE HOT-MELT SILICONE COMPOSITION OR CURED PRODUCT THEREOF | DOW TORAY CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| EP-0459381-B1 | Process for the preparation of 10-(2-propynyl)ester-4-ene-3,17-dione | MERRELL PHARMA INC (US) | 1997-03-19 | — | — | EP | disclosed |
| US-5516922-A | Process for the preparation of 10(2-propynyl)estr-4-ene-3,17-dione | MERRELL PHARMACEUTICALS INC. (US) | 1996-05-14 | — | — | US | disclosed |
| EP-0459381-A2 | Process for the preparation of 10-(2-propynyl)ester-4-ene-3,17-dione | MERRELL PHARMACEUTICALS INC. (US) | 1991-12-04 | — | — | EP | disclosed |